PL3082845T3 - Sposoby i kompozycje do leczenia neuropatii obwodowych - Google Patents
Sposoby i kompozycje do leczenia neuropatii obwodowychInfo
- Publication number
- PL3082845T3 PL3082845T3 PL14872066T PL14872066T PL3082845T3 PL 3082845 T3 PL3082845 T3 PL 3082845T3 PL 14872066 T PL14872066 T PL 14872066T PL 14872066 T PL14872066 T PL 14872066T PL 3082845 T3 PL3082845 T3 PL 3082845T3
- Authority
- PL
- Poland
- Prior art keywords
- compositions
- treatment
- methods
- peripheral neuropathies
- neuropathies
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 208000027232 peripheral nervous system disease Diseases 0.000 title 1
- 208000033808 peripheral neuropathy Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Ophthalmology & Optometry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361919301P | 2013-12-20 | 2013-12-20 | |
| EP14872066.7A EP3082845B1 (en) | 2013-12-20 | 2014-12-17 | Methods and compositions for treatment of peripheral neuropathies |
| PCT/CA2014/051227 WO2015089664A1 (en) | 2013-12-20 | 2014-12-17 | Methods and compositions for treatment of peripheral neuropathies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3082845T3 true PL3082845T3 (pl) | 2021-08-02 |
Family
ID=53401865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14872066T PL3082845T3 (pl) | 2013-12-20 | 2014-12-17 | Sposoby i kompozycje do leczenia neuropatii obwodowych |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US20170027957A1 (pl) |
| EP (2) | EP3895705A3 (pl) |
| CN (3) | CN120661657A (pl) |
| CA (1) | CA2934578A1 (pl) |
| ES (1) | ES2865624T3 (pl) |
| PL (1) | PL3082845T3 (pl) |
| WO (1) | WO2015089664A1 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3917509A4 (en) | 2019-01-28 | 2022-11-09 | Mitochondria Emotion, Inc. | TRANS-4-HYDROXYCYCLOHEXYLPHENYLAMIDE MITOFUSIN ACTIVATORS AND METHODS OF USE THEREOF |
| WO2020159576A1 (en) | 2019-01-28 | 2020-08-06 | Mitochondria Emotion, Inc. | Mitofusin activators and methods of use thereof |
| IL286340B1 (en) * | 2019-03-26 | 2025-10-01 | Winsantor Inc | Topical formulations for the treatment of peripheral nervous system diseases |
| SG10201907677QA (en) * | 2019-08-20 | 2021-03-30 | Yin Sze Loh | Formulations for use in the prevention and/or treatment of peripheral neuropathy and its associated diseases. |
| EP3988122A4 (en) * | 2019-12-17 | 2023-01-18 | Yizhou (Shanghai) Biological Medicine Co, Ltd. | APPLICATION OF TRANSTHYRETIN IN PENETRATION INTO THE EYE AND PREPARATION OF DROPS |
| US11793754B1 (en) | 2022-06-16 | 2023-10-24 | King Abdulaziz University | Sodium hypochlorite and chlorhexidine based nanoemulsions and a method of preparation thereof |
| WO2024120461A1 (zh) * | 2022-12-09 | 2024-06-13 | 荣昌生物制药(烟台)股份有限公司 | Cyp3a4/5诱导剂在治疗或缓解周围神经病变中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1147400A1 (ru) * | 1981-05-18 | 1985-03-30 | Научно-Исследовательский Институт Экспериментальной Медицины Амн Ссср | Способ лечени поражений периферических нервов |
| EP2275095A3 (en) * | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| GB0602857D0 (en) * | 2006-02-13 | 2006-03-22 | Daniolabs Ltd | The treatment of sialorrhoea |
| WO2009051844A1 (en) * | 2007-10-17 | 2009-04-23 | Neuren Pharmaceuticals Limited | Synthetic analogues of neural regeneration peptides |
| US10307428B2 (en) * | 2010-10-25 | 2019-06-04 | University Health Network | Therapeutic compositions for diabetic symmetrical polyneuropathy |
| WO2012112933A1 (en) * | 2011-02-18 | 2012-08-23 | The Scripps Research Institute | Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate |
-
2014
- 2014-12-17 EP EP21156057.8A patent/EP3895705A3/en active Pending
- 2014-12-17 WO PCT/CA2014/051227 patent/WO2015089664A1/en not_active Ceased
- 2014-12-17 CN CN202510216383.4A patent/CN120661657A/zh active Pending
- 2014-12-17 EP EP14872066.7A patent/EP3082845B1/en active Active
- 2014-12-17 CA CA2934578A patent/CA2934578A1/en active Pending
- 2014-12-17 ES ES14872066T patent/ES2865624T3/es active Active
- 2014-12-17 CN CN202011011663.5A patent/CN112057626A/zh active Pending
- 2014-12-17 PL PL14872066T patent/PL3082845T3/pl unknown
- 2014-12-17 CN CN201480075321.6A patent/CN106061497A/zh active Pending
- 2014-12-17 US US15/106,778 patent/US20170027957A1/en not_active Abandoned
-
2021
- 2021-03-19 US US17/206,498 patent/US20210267998A1/en not_active Abandoned
-
2024
- 2024-04-26 US US18/647,336 patent/US20250090545A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250090545A1 (en) | 2025-03-20 |
| CN106061497A (zh) | 2016-10-26 |
| EP3895705A3 (en) | 2022-03-09 |
| EP3082845A4 (en) | 2017-10-25 |
| EP3082845A1 (en) | 2016-10-26 |
| US20210267998A1 (en) | 2021-09-02 |
| EP3895705A2 (en) | 2021-10-20 |
| EP3082845B1 (en) | 2021-02-17 |
| US20170027957A1 (en) | 2017-02-02 |
| CN120661657A (zh) | 2025-09-19 |
| CA2934578A1 (en) | 2015-06-25 |
| CN112057626A (zh) | 2020-12-11 |
| ES2865624T3 (es) | 2021-10-15 |
| WO2015089664A1 (en) | 2015-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273090B (en) | Methods and preparations for the treatment of cancer | |
| GB201320723D0 (en) | Composition and methods of treatment | |
| EP2958936A4 (en) | METHOD AND COMPOSITIONS FOR TREATING CORI DISEASE | |
| SG11201601412XA (en) | Compositions and methods for the treatment of presbyopia | |
| IL239453A0 (en) | Preparations and methods for treating cancer using bacteria | |
| IL244089A0 (en) | Diagnostic methods and preparations for the treatment of glioblastoma | |
| IL238177A0 (en) | Methods and preparations for the treatment of cancer | |
| PT3021839T (pt) | Composições para o tratamento da fibrose | |
| IL239851B (en) | Methods and compositions for treating diseases that act to remove myelin | |
| ZA201408056B (en) | Compositions and methods for the treatment of mucositis | |
| ZA201408055B (en) | Compositions and methods for the treatment of local pain | |
| EP3082427A4 (en) | Compositions and methods for treatment of glaucoma | |
| PL3082845T3 (pl) | Sposoby i kompozycje do leczenia neuropatii obwodowych | |
| SG10201710538XA (en) | Compositions and methods for treating skin | |
| PL2968478T3 (pl) | Kompozycje i sposoby do leczenia karboksyhemoglobinemii | |
| EP3068431A4 (en) | Methods and compositions for the treatment of hcmv | |
| ZA201509360B (en) | Compositions and methods for treatment of stroke | |
| ZA201408065B (en) | Compositions and methods for the treatment of diabetes | |
| PL3079684T3 (pl) | Kompozycje i sposoby do leczenia chorób związanych z układem renina-angiotensyna | |
| HUE040421T2 (hu) | Készítmények és eljárások 1-es típusú cukorbetegség kezelésére | |
| AU2013902004A0 (en) | Compositions for Therapy and Methods of Treatment | |
| GB201309001D0 (en) | Methods for prevention and treatment of preeclampsia |